Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.

Lewin J, Soltan Ghoraie L, Bedard PL, Hamilton RJ, Chung P, Moore M, Jewett MAS, Anson-Cartwright L, Virtanen C, Winegarden N, Tsao J, Warde P, Sweet J, Haibe-Kains B, Hansen AR.

BJU Int. 2018 May 3. doi: 10.1111/bju.14372. [Epub ahead of print]

PMID:
29726090
2.

Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.

Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ.

J Urol. 2018 Jul;200(1):126-135. doi: 10.1016/j.juro.2018.02.068. Epub 2018 Feb 21.

PMID:
29474847
3.

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, Lewin J, Atenafu EG, Sweet J, Anson-Cartwright L, Boström P, Chung P, Warde P, Bedard PL, Bagrodia A, Freifeld Y, Power N, Winquist E, Hamilton RJ.

Eur Urol Focus. 2018 Feb 7. pii: S2405-4569(18)30016-6. doi: 10.1016/j.euf.2018.01.015. [Epub ahead of print]

PMID:
29428550
4.

Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell Tumors.

Kwan EM, Beck S, Amir E, Jewett MA, Sturgeon JF, Anson-Cartwright L, Chung PW, Warde PR, Moore MJ, Bedard PL, Tran B.

Clin Genitourin Cancer. 2017 Sep 4. pii: S1558-7673(17)30267-7. doi: 10.1016/j.clgc.2017.08.012. [Epub ahead of print]

PMID:
28943331
5.

The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.

Nayan M, Jewett MA, Anson-Cartwright L, Bedard PL, Moore M, Chung P, Warde P, Sweet J, O'Malley M, Hamilton RJ.

Can Urol Assoc J. 2016 May-Jun;10(5-6):204-209.

6.

Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.

Nayan M, Jewett MA, Hosni A, Anson-Cartwright L, Bedard PL, Moore M, Hansen AR, Chung P, Warde P, Sweet J, O'Malley M, Atenafu EG, Hamilton RJ.

Eur Urol. 2017 Jan;71(1):120-127. doi: 10.1016/j.eururo.2016.07.013. Epub 2016 Aug 12.

PMID:
27527805
7.

Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.

Nayan M, Jewett MA, Sweet J, Anson-Cartwright L, Bedard PL, Moore M, Chung P, Warde P, Hamilton RJ.

J Urol. 2015 Aug;194(2):386-91. doi: 10.1016/j.juro.2015.03.100. Epub 2015 Mar 28.

PMID:
25823792
8.

Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.

Srikanthan A, Tran B, Beausoleil M, Jewett MA, Hamilton RJ, Sturgeon JF, O'Malley M, Anson-Cartwright L, Chung PW, Warde PR, Winquist E, Moore MJ, Amir E, Bedard PL.

J Clin Oncol. 2015 Feb 20;33(6):582-7. doi: 10.1200/JCO.2014.58.6537. Epub 2015 Jan 20.

PMID:
25605848
9.

Utility of serum tumor markers during surveillance for stage I seminoma.

Vesprini D, Chung P, Tolan S, Gospodarowicz M, Jewett M, O'Malley M, Sweet J, Moore M, Panzarella T, Sturgeon J, Sugar L, Anson-Cartwright L, Warde P.

Cancer. 2012 Nov 1;118(21):5245-50. doi: 10.1002/cncr.27539. Epub 2012 Apr 19.

10.

Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.

Sturgeon JF, Moore MJ, Kakiashvili DM, Duran I, Anson-Cartwright LC, Berthold DR, Warde PR, Gospodarowicz MK, Alison RE, Liu J, Ma C, Pond GR, Jewett MA.

Eur Urol. 2011 Apr;59(4):556-62. doi: 10.1016/j.eururo.2010.12.010. Epub 2010 Dec 22.

PMID:
21190791
11.

Canadian consensus guidelines for the management of testicular germ cell cancer.

Wood L, Kollmannsberger C, Jewett M, Chung P, Hotte S, O'Malley M, Sweet J, Anson-Cartwright L, Winquist E, North S, Tyldesley S, Sturgeon J, Gospodarowicz M, Segal R, Cheng T, Venner P, Moore M, Albers P, Huddart R, Nichols C, Warde P.

Can Urol Assoc J. 2010 Apr;4(2):e19-38. No abstract available.

12.

Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire.

Mancuso C, Glendon G, Anson-Cartwright L, Shi EJ, Andrulis I, Knight J.

Ann Epidemiol. 2004 Jan;14(1):36-43.

PMID:
14664778
13.

Transcription factors underlying the development and endocrine functions of the placenta.

Cross JC, Anson-Cartwright L, Scott IC.

Recent Prog Horm Res. 2002;57:221-34. Review.

PMID:
12017545
14.

The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta.

Anson-Cartwright L, Dawson K, Holmyard D, Fisher SJ, Lazzarini RA, Cross JC.

Nat Genet. 2000 Jul;25(3):311-4.

PMID:
10888880
15.
16.

The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms.

Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC.

Mol Cell Biol. 2000 Jan;20(2):530-41.

17.

Drosophila engrailed can substitute for mouse Engrailed1 function in mid-hindbrain, but not limb development.

Hanks MC, Loomis CA, Harris E, Tong CX, Anson-Cartwright L, Auerbach A, Joyner A.

Development. 1998 Nov;125(22):4521-30.

18.

The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.

Riley P, Anson-Cartwright L, Cross JC.

Nat Genet. 1998 Mar;18(3):271-5.

PMID:
9500551
19.

Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2.

Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL.

Science. 1995 Aug 4;269(5224):679-82.

PMID:
7624797
20.

Identification of a gene from Xp21 with similarity to the tctex-1 gene of the murine t complex.

Roux AF, Rommens J, McDowell C, Anson-Cartwright L, Bell S, Schappert K, Fishman GA, Musarella M.

Hum Mol Genet. 1994 Feb;3(2):257-63.

PMID:
8004092
21.

Linkage analysis in X-linked ocular albinism.

Schnur RE, Nussbaum RL, Anson-Cartwright L, McDowell C, Worton RG, Musarella MA.

Genomics. 1991 Apr;9(4):605-13.

PMID:
1674724
22.

Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families.

Musarella MA, Anson-Cartwright L, Leal SM, Gilbert LD, Worton RG, Fishman GA, Ott J.

Genomics. 1990 Oct;8(2):286-96.

PMID:
1979051
23.

Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3.

Musarella MA, Weleber RG, Murphey WH, Young RS, Anson-Cartwright L, Mets M, Kraft SP, Polemeno R, Litt M, Worton RG.

Genomics. 1989 Nov;5(4):727-37.

PMID:
2574143
24.

Linkage analysis of a large Latin-American family with X-linked retinitis pigmentosa and metallic sheen in the heterozygote carrier.

Musarella MA, Anson-Cartwright L, Burghes A, Worton RG, Lesko JG, Nussbaum RL.

Genomics. 1989 May;4(4):601-5.

PMID:
2568332
25.

Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis.

Musarella MA, Burghes A, Anson-Cartwright L, Mahtani MM, Argonza R, Tsui LC, Worton R.

Am J Hum Genet. 1988 Oct;43(4):484-94.

26.

Bloom syndrome: a single complementation group defines patients of diverse ethnic origin.

Weksberg R, Smith C, Anson-Cartwright L, Maloney K.

Am J Hum Genet. 1988 Jun;42(6):816-24.

Supplemental Content

Loading ...
Support Center